title: Flavopiridol Induces Apoptosis via Mitochondrial Pathway in B16F10 Murine Melanoma Cells and a Subcutaneous Melanoma Tumor Model.
abstract: Flavopiridol is a cyclin-dependent kinase (CDK) inhibitor that promotes cell cycle arrest. We aimed to examine the anti-proliferative effects of the flavopiridol and oxaliplatin combination on p16INK4A deficient melanoma cells B16F10 and also its apoptotic effects on a subcutaneously injected B16F10 allograft melanoma tumor model. Flavopiridol and oxaliplatin treated B16F10 cell viability was determined by MTT assay. C57BL6 mice were injected with B16F10 cells and treated with flavopiridol after tumor implantation. BRAF and BCL2L1 mRNA expression levels were measured using reverse transcription-polymerase chain reaction (RT-PCR). Caspase 9 and caspase 3/7 activity were determined by activity assay kits. Proliferating cell nuclear antigen (PCNA) and B-cell lymphoma 2 (BCL-2) protein expression levels were analyzed immunohistochemically. Flavopiridol and oxaliplatin decreased cell death. Flavopiridol enhanced caspase 3/7 and caspase 9 activities in vitro and in vivo in a dose dependent manner via the mitochondrial apoptotic pathway. Even though there was a significant increase in Bcl-2 staining, PCNA staining was decreased in flavopiridol-administered mice. Decreased PCNA expression showed antiproliferative effects of flavopiridol which might be the result of cell-cycle arrest. Flavopiridol can be used as a cell cycle inhibitor.
authors.forename: Ozlem
authors.initials: O
authors.lastname: Gokce
authors.affiliation: Irem Dogan Turacli, PhD, Ufuk University, Faculty of Medicine, Department of Medical Biology, Ankara, Turkey; doganirem@gmail.com.
authors.forename: Irem
authors.initials: I
authors.lastname: Dogan Turacli
authors.forename: Hacer
authors.initials: H
authors.lastname: Ilke Onen
authors.forename: Ozlem
authors.initials: O
authors.lastname: Erdem
authors.forename: Elif
authors.initials: E
authors.lastname: Erguven Kayaa
authors.forename: Abdullah
authors.initials: A
authors.lastname: Ekmekci
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D020169:Caspases / Q000378:metabolism*; D018929:Cell Culture Techniques; D004195:Disease Models, Animal; D005419:Flavonoids / Q000494:pharmacology*; D008545:Melanoma / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009944:Organoplatinum Compounds / Q000494:pharmacology; D000077150:Oxaliplatin; D010880:Piperidines / Q000494:pharmacology*; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D012878:Skin Neoplasms / Q000378:metabolism / Q000473:pathology*; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D005419:Flavonoids; D009944:Organoplatinum Compounds; D010880:Piperidines; D018809:Proliferating Cell Nuclear Antigen; D000077150:Oxaliplatin; C077990:alvocidib; D020169:Caspases